Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
Clinical trial NCT00524576 · COMPLETED
Trial details
- NCT number
- NCT00524576
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-28
- Primary completion
- 2008-05-14
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.